 Home > Active Ingredient News > Drugs Articles > Novo Nordisk's new diabetes drug enters "pending approval", a long-acting GLP-1 analogue once a week

Novo Nordisk's new diabetes drug enters "pending approval", a long-acting GLP-1 analogue once a week

 Last Update: 2021-05-10
 Source: Internet
 Author: User

Tags

healthy weight calculator

food drug administration

drug reaction

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On April 19, the results of the drug registration progress inquiry of China's National Food and Drug Administration (NMPA) showed that Novo Nordisk (Novo Nordisk) submitted a new drug listing application for smegaglutide injection, the status has been updated to "pending approval.

" This means that the registration of this long-acting GLP-1 analog, which only needs to be injected once a week, has gone further in China.
If approved successfully, it will bring new treatment options to Chinese patients with type 2 diabetes.

Type 2 diabetes is a serious disease.

This disease is often caused by the inability of the body to produce enough insulin or the inability to properly use the insulin synthesized by the body.

Semaglutide (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog, which can act as a GLP-1 receptor agonist and can bring cardiovascular and metabolic gains to patients.

According to the results of the SUSTAIN China study recently released by Novo Nordisk, this study is a registered clinical trial of smeglutide in China.

The results showed that after 30 weeks, smeglutide significantly reduced HbA1c by 1.

The review and approval status of smegaglutide in China's listing application has entered pending approval, which means that this product is one step closer to being approved in China.

Pharmaceutical Mission Hills

Observe the waves of Chinese medicine and compose the chapter of global new medicine.

1332 original content

the public

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

N-Methyl-L-alanine3913-67-5

CAS No.: 3913-67-5

Industrial Grade

$1-1.04/KG FOB

High Purity 99% PEG MGF CAS 108174-48-7 Customized Peptides from China OUDA

CAS No.: 108174-48-7

Pharmacy Grade

$2-2.6/G FOB

Wholesales Purity 99 Peptides Powder Sema Tirz Retatrutide 5mg/10mg/15mg to Door From China

CAS No.: 2023788-19-2

Pharmacy Grade

$150-180/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.